Hinge Health, Inc. (HNGE)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
Market Cap: $9.38B
Last updated: Nov 17, 2026 at 11:06 AM ET
Hinge Health, Inc. (HNGE) Stock Forecast
Analysts expect Hinge Health (HNGE) to earn $2.57 per share in the fiscal year ending Dec 31, 2026, on revenue of $877.95M. Of 17 analysts, 16 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 12 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 17 ratings average 1.65, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 94% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 7 | 41.2% |
| Buy | 9 | 52.9% |
| Hold | 1 | 5.9% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 17
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 26.8% and revenue estimates rise 27.6%.
- Fiscal year ending Dec 31, 2026
- $2.57
- EPS consensus, revenue $877.95M
- Fiscal year ending Dec 31, 2027
- $3.26
- EPS consensus, revenue $1.12B
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.57 | $2.30 to $3.50 | 14 | $877.95M | $857.10M to $886.20M | 16 |
| Dec 31, 2027 | $3.26 | $2.70 to $4.89 | 14 | $1.12B | $1.04B to $1.20B | 16 |
Quarterly Estimates
The EPS consensus falls from $0.73 for the quarter ending Dec 31, 2026 to $0.64 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.73 | $0.56 to $0.84 | 19 | $253.71M | $225.40M to $268.91M | 18 |
| Mar 31, 2027 | $0.64 | $0.54 to $0.72 | 12 | $248.57M | $232.80M to $255.00M | 13 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 23 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 12 | 1 |
| Fiscal year ending Dec 31, 2027 | 11 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 5.8% from $2.43.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.57 | $2.24 | $2.40 | $2.40 | $2.43 | +5.8% |
| Fiscal year ending Dec 31, 2027 | $3.26 | $3.06 | $3.06 | $3.06 | $3.13 | +4.0% |
| Quarter ending Mar 31, 2027 | $0.64 | $0.61 | $0.61 | $0.61 | $0.63 | +3.0% |
Frequently Asked Questions About HNGE
What is the HNGE stock forecast?
Consensus analyst estimates put Hinge Health's EPS at $2.57 for the fiscal year ending Dec 31, 2026, on revenue of $877.95M. The consensus rating from 17 analysts is Buy.
How do analysts rate HNGE stock?
Of 17 analysts covering Hinge Health, 7 rate it Strong Buy, 9 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from HNGE next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.57, with estimates from $2.30 to $3.50 from 14 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $3.26, with estimates from $2.70 to $4.89 from 14 analysts.
What revenue do analysts expect from Hinge Health next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $877.95M, with estimates from $857.10M to $886.20M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.12B, with estimates from $1.04B to $1.20B.
How many analysts cover HNGE?
17 analysts rate Hinge Health stock, and 14 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
HNGE pages: Overview, Forecast, Valuation, Competitors